Survival outcomes of patients with relapsed or refractory ML-DS according to treatment. (A) OS and (B) EFS for patients treated with chemotherapy alone or chemotherapy followed by hematopoietic stem cell transplantation (HSCT, analyzed time-dependent covariate). (C) OS and (D) EFS for patients with relapsed or refractory ML-DS according to remission status before HSCT.